Company: INDP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021759
Chunk: 70

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 8
Chunk 70
---
 reporting.

9

Part
II. OTHER INFORMATION

Item
1. Legal Proceedings

From
time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation
is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

There
are currently no pending material legal proceedings, and we are currently not aware of any legal proceedings or claims against us or
our property that we believe will have any significant effect on our business, financial position or operating results. None of our officers
or directors is a party against us in any legal proceeding.

Item
1A. Risk Factors

Except
as set forth below in this Item 1A and the Risk Factors included in our previous filings made with the SEC, there have been no material
changes to our risk factors from those disclosed in “Part I. Item 1A. Risk Factors” in the Form 10-K filed with the SEC on
March 13, 2025.

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item
3. Defaults Upon Senior Securities

Not
applicable.

Item
4. Mine Safety Disclosures

Not
applicable.

Item
5. Other Information

During
the three months ended September 30, 2025, no director or “officer” (as defined in Rule 16a-1(f) under the Exchange Act)
of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”
as each term is defined in Item 408(a) of Regulation S-K.

Item
6. Exhibits 

    Exhibit
    No.
     
    Exhibit
    Description
  
    3.1
     
    Amended and Restated Certificate of Incorporation of Indaptus Therapeutics, Inc., dated as of July 23, 2021 (incorporated herein by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 23, 2021)
  
    3.2
     
    Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Indaptus Therapeutics, Inc. dated August 3, 2021 (incorporated herein by reference to Exhibit 3.1 of the Company’s Current